Salmonella gallinarum is a bacterium that causes fowl typhoid, a severe systemic disease in poultry . Salmonella employs various mechanisms to infect its host, and understanding these mechanisms is vital for developing effective control strategies . Fumarate reductase is an enzyme that plays a crucial role in anaerobic respiration, allowing bacteria to thrive in environments with limited oxygen . The frdD gene encodes one of the subunits of fumarate reductase . Recombinant Salmonella gallinarum Fumarate reductase subunit D (frdD) refers to the frdD subunit that is produced using recombinant DNA technology, typically in E. coli .
Recombinant Production: The frdD gene from Salmonella gallinarum is inserted into a plasmid, which is then introduced into E. coli cells. These cells are cultured to express the frdD protein, which is then purified for research purposes .
Purity: Recombinant proteins are produced to a high degree of purity to ensure that experiments are not affected by other proteins or contaminants .
Fumarate reductase is essential for anaerobic respiration in bacteria, catalyzing the reduction of fumarate to succinate . This process allows Salmonella to generate energy in the absence of oxygen, which is particularly important during infection within the host tissues .
The frdD subunit, as part of the fumarate reductase complex, contributes to the virulence of Salmonella gallinarum . By enabling anaerobic respiration, fumarate reductase helps the bacteria to:
Survive in Host Tissues: During infection, Salmonella encounters oxygen-limited environments within the host. Fumarate reductase allows the bacteria to continue producing energy, enhancing its survival .
Colonize the Host: Anaerobic respiration supports the metabolic needs of Salmonella during the colonization process, aiding in its proliferation and persistence in the host .
Evade Immune Responses: By surviving in low-oxygen conditions, Salmonella can persist within immune cells, such as macrophages, and evade the host’s immune responses .
Recombinant Salmonella gallinarum frdD is used in various research applications to study Salmonella pathogenesis and develop new control strategies:
Vaccine Development: Attenuated Salmonella strains, including those with deletions in virulence-associated genes like frdD, are being explored as live vaccines. These strains can stimulate the host's immune system without causing disease .
Immunological Studies: Recombinant frdD can be used to study the immune responses to Salmonella gallinarum, including the production of antibodies and the activation of immune cells .
Drug Target Identification: Understanding the role of fumarate reductase in Salmonella virulence can help identify potential drug targets. Inhibitors of fumarate reductase could be developed to impair Salmonella's ability to cause disease .
| Time Post-Infection (DPI) | Group A (SG Δ purB) Liver (CFU/g) | Group A (SG Δ purB) Spleen (CFU/g) | Group B (SG wild-type) Liver (CFU/g) | Group B (SG wild-type) Spleen (CFU/g) |
|---|---|---|---|---|
| 3 | 3.11 ± 0.23 | 3.21 ± 0.19 | 5.50 ± 0.17 | 5.12 ± 0.21 |
| 7 | 2.19 ± 0.19 | 2.58 ± 0.25 | 6.34 ± 0.32 | 5.98 ± 0.24 |
| 10 | 0.98 ± 0.20 | 1.34 ± 0.21 | 5.76 ± 0.22 | 4.89 ± 0.22 |
| 14 | 0.0 ± 0.0 | 0.0 ± 0.0 | 4.54 ± 0.21 | 3.88 ± 0.21 |
| 21 | 0.0 ± 0.0 | 0.0 ± 0.0 | 3.49 ± 0.16 | 2.89 ± 0.29 |
Note: Adapted from reference . The purB deletion mutant shows reduced colonization in both the liver and spleen compared to the wild-type Salmonella gallinarum.
In one study, chickens immunized with a recombinant Salmonella gallinarum strain expressing APEC type I fimbriae showed significant IgG and sIgA responses . The concentrations were:
IgG: 221.50 μg/mL
sIgA: 1.68 μg/mL
These data indicate that recombinant Salmonella gallinarum can induce strong humoral and mucosal immune responses, which are crucial for protection against Salmonella and other pathogens .
KEGG: seg:SG4183